FDA Approved: CARVEDILOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for carvedilol, a generic beta-blocker, for a new or expanded generic product indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• Carvedilol (generic) (Carvedilol)

Snippet

SUPPL AP for CARVEDILOL (CARVEDILOL)